{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:28:23Z","timestamp":1789111703692,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Theravance Theravance Biopharma US, Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1544-y","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T09:45:48Z","timestamp":1494927948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multidimensional daily diary of fatigue\u2013fibromyalgia\u201317 items (MDF-fibro-17). part 1: development and content validity"],"prefix":"10.1186","volume":"18","author":[{"given":"S.","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dube\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-7169","authenticated-orcid":false,"given":"C.","family":"Burbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"1544_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the united states. Part II Arthritis Rheum. 2008;58:26\u201335.","journal-title":"Part II Arthritis Rheum"},{"key":"1544_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160\u201372.","journal-title":"Arthritis Rheum"},{"key":"1544_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19\u201328.","journal-title":"Arthritis Rheum"},{"key":"1544_CR4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1544_CR5","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/art.34390","volume":"64","author":"LM Arnold","year":"2012","unstructured":"Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum. 2012;64:2387\u201397.","journal-title":"Arthritis Rheum"},{"key":"1544_CR6","doi-asserted-by":"crossref","unstructured":"Burbridge C, Symonds T, Humphrey L, Arbuckle R, Hirsch I, Whelan L. Validation of the Daily Diary of Fatigue Symptoms \u2013 Fibromyalgia (DFS-Fibro). Open J Rheumatol Autoimmune Dis. 2013;3:92\u2013103.\u00a0","DOI":"10.4236\/ojra.2013.32014"},{"key":"1544_CR7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1742-1241.2010.02418.x","volume":"64","author":"S Perrot","year":"2010","unstructured":"Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K, et al. Characteristics of patients with fibromyalgia in France and Germany. Int J Clin Pract. 2010;64:1100\u20138.","journal-title":"Int J Clin Pract"},{"key":"1544_CR8","first-page":"1318","volume":"30","author":"RL Robinson","year":"2003","unstructured":"Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol. 2003;30:1318\u201325.","journal-title":"J Rheumatol"},{"key":"1544_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-9-71","volume":"9","author":"C Schaefer","year":"2011","unstructured":"Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, et al. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011;9:71.","journal-title":"Health Qual Life Outcomes"},{"key":"1544_CR10","unstructured":"Mapi Values UK. Fatigue, physical and cognitive functioning in Fibromyalgia: Findings from the concept elicitation patient interviews (internal report, unpublished). Report PI5912A v18.0. 2009."},{"key":"1544_CR11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1529-0131(199901)42:1<76::AID-ANR10>3.0.CO;2-G","volume":"42","author":"KP White","year":"1999","unstructured":"White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London fibromyalgia epidemiology study. Arthritis Rheum. 1999;42:76\u201383.","journal-title":"Arthritis Rheum"},{"key":"1544_CR12","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar3359","volume":"13","author":"LM Arnold","year":"2011","unstructured":"Arnold LM, Wang F, Ahl J, Gaynor PJ, Wohlreich MM. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial. Arthritis Res Ther. 2011;13:R86.","journal-title":"Arthritis Res Ther"},{"key":"1544_CR13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3899\/jrheum.090139","volume":"36","author":"JI Hudson","year":"2009","unstructured":"Hudson JI, Arnold LM, Bradley LA, Choy EH, Mease PJ, Wang F, et al. What makes patients with fibromyalgia feel better? correlations between patient global impression of improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. J Rheumatol. 2009;36:2517\u201322.","journal-title":"J Rheumatol"},{"key":"1544_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2474-11-216","volume":"11","author":"L Humphrey","year":"2010","unstructured":"Humphrey L, Arbuckle R, Mease P, Williams DA, Samsoe BD, Gilbert C. Fatigue in fibromyalgia: a conceptual model informed by patient interviews. BMC Musculoskelet Disord. 2010;11:216.","journal-title":"BMC Musculoskelet Disord"},{"key":"1544_CR15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.23826","volume":"59","author":"PJ Mease","year":"2008","unstructured":"Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum. 2008;59:952\u201360.","journal-title":"Arthritis Rheum"},{"key":"1544_CR16","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3002","volume":"12","author":"W Hauser","year":"2010","unstructured":"Hauser W, Klose P, Langhorst J, Moradi B, Steinbach M, Schiltenwolf M, et al. Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther. 2010;12:R79.","journal-title":"Arthritis Res Ther"},{"key":"1544_CR17","first-page":"1415","volume":"34","author":"P Mease","year":"2007","unstructured":"Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol. 2007;34:1415\u201325.","journal-title":"J Rheumatol"},{"key":"1544_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","volume":"36","author":"PJ Mease","year":"2009","unstructured":"Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398\u2013409.","journal-title":"J Rheumatol"},{"key":"1544_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004650-200204000-00009","volume":"16","author":"SA Cudney","year":"2002","unstructured":"Cudney SA, Butler MR, Weinert C, Sullivan T. Ten rural women living with fibromyalgia tell it like it is. Holist Nurs Pract. 2002;16:35\u201345.","journal-title":"Holist Nurs Pract"},{"key":"1544_CR20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1054773806291853","volume":"15","author":"MM Cunningham","year":"2006","unstructured":"Cunningham MM, Jillings C. Individuals\u2019 descriptions of living with fibromyalgia. Clin Nurs Res. 2006;15:258\u201373.","journal-title":"Clin Nurs Res"},{"key":"1544_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/028134399750002827","volume":"17","author":"O Hellstrom","year":"1999","unstructured":"Hellstrom O, Bullington J, Karlsson G, Lindqvist P, Mattsson B. A phenomenological study of fibromyalgia. Patient perspectives. Scand J Prim Health Care. 1999;17:11\u20136.","journal-title":"Scand J Prim Health Care"},{"key":"1544_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004650-200501000-00007","volume":"19","author":"KM Schaefer","year":"2005","unstructured":"Schaefer KM. The lived experience of fibromyalgia in African American women. Holist Nurs Pract. 2005;19:17\u201325.","journal-title":"Holist Nurs Pract"},{"key":"1544_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1891\/rtnp.16.1.19.52994","volume":"16","author":"M Sturge-Jacobs","year":"2002","unstructured":"Sturge-Jacobs M. The experience of living with fibromyalgia: confronting an invisible disability. Res Theory Nurs Pract. 2002;16:19\u201331.","journal-title":"Res Theory Nurs Pract"},{"key":"1544_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","volume":"145","author":"W Hauser","year":"2009","unstructured":"Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain. 2009;145:69\u201381.","journal-title":"Pain"},{"key":"1544_CR25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.24276","volume":"61","author":"W Hauser","year":"2009","unstructured":"Hauser W, Bernardy K, Arnold B, Offenbacher M, Schiltenwolf M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 2009;61:216\u201324.","journal-title":"Arthritis Rheum"},{"key":"1544_CR26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","volume":"26","author":"W Hauser","year":"2012","unstructured":"Hauser W, Wolfe F, Tolle T, Uceyler N, Sommer C. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26:297\u2013307.","journal-title":"CNS Drugs"},{"key":"1544_CR27","first-page":"132","volume":"59","author":"W Hauser","year":"2013","unstructured":"Hauser W, Burgmer M, Kollner V, Schaefert R, Eich W, Hausteiner-Wiehle C, et al. Fibromyalgia syndrome as a psychosomatic disorder - diagnosis and therapy according to current evidence-based guidelines. Z Psychosom Med Psychother. 2013;59:132\u201352.","journal-title":"Z Psychosom Med Psychother"},{"key":"1544_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, de Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315\u201325.","journal-title":"J Psychosom Res"},{"key":"1544_CR29","unstructured":"Patient-Reported Outcome Measures. Use in Medical Product Development to Support Labeling Claims. 2009.\u00a0\nhttp:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf\n\n."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T09:46:04Z","timestamp":1494927964000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1544-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]},"article-number":"195"}}